The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Budget impact (BI) analysis of cemiplimab for first-line (1L) advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50% in the United States.
 
Andreas Kuznik
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Caitlin Smare
Employment - Precision Value & Health
Consulting or Advisory Role - Precision Value & Health
Research Funding - Precision Value & Health
 
Chieh-I Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Meena Venkatachalam
Employment - Precision HEOR
Stock and Other Ownership Interests - Precision HEOR
Consulting or Advisory Role - Precision HEOR
 
Sam Keeping
Employment - PRECISIONHeor
 
Kokuvi Atsou
Employment - Sanofi/Aventis
Stock and Other Ownership Interests - Sanofi/Aventis
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Yingxin Xu
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Florence Wilson
Employment - Precision HEOR
Research Funding - Regeneron (Inst)
 
Patricia Guyot
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Research Funding - Sanofi
 
Keith Chan
Employment - Precision HEOR
Research Funding - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis; Regeneron; Sanofi; Takeda
 
Emily Glowienka
Employment - Precision HEOR
Research Funding - Regeneron (Inst)
 
Gerasimos Konidaris
Employment - Sanofi